Karen J. Wilson - Jan 14, 2025 Form 3 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
Karen J. Wilson
Stock symbol
SER
Transactions as of
Jan 14, 2025
Transactions value $
$0
Form type
3
Date filed
1/15/2025, 04:17 PM
Previous filing
Jan 2, 2025
Next filing
Feb 18, 2025

No securities are beneficially owned.